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Abstract  
Objective: Determine baseline knowledge of antimicrobial stewardship, and safe prescribing among junior medical officers, monitor 
their level of participation in interactive education during protected teaching time and assess day-to-day prescribing behaviours over 
the subsequent 3-month period.   
Methods: A voluntary and anonymous survey of all non-consultant level medical officers was conducted with the use of an audience 
response system during mandatory face-to-face orientation sessions at a tertiary paediatric hospital. Routine prescribing audits 
monitored compliance with national and locally derived quality use of medicines indicators. 
Results: Eighty-six percent of medical officers participated by responding to at least one question (171/200). Response rate for 
individual questions ranged between 31% and 78%. Questions that addressed adverse drug reactions, documentation and monitoring 
for empiric antibiotics and the error-prone abbreviations IU and U were correctly answered by over 90% of participants. Other non-
standard and error-prone abbreviations were less consistently identified. In practice, 68% of patients had complete adverse drug 
reaction documentation (113/166). Error-prone abbreviations were identified on 5% of audited medication orders (47/976), 
approximately half included a documented indication and intended dose.  
Conclusions: Participants demonstrated a good understanding of safe prescribing and antimicrobial stewardship. Audits of prescribing 
identified potential discrepancies between prescribing knowledge and behaviours. 
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INTRODUCTION 
Safe  and appropriate prescribing requires knowledge of 
patient and medication factors as well as the skills to 
effectively gather information and communicate clinical 
decisions to staff and patients.1,2 Medication errors may 
result from illegible or incomplete prescriptions, use of 
error-prone abbreviations, missed drug interactions or 
failure to adequately monitor treatment.3  
Pharmacokinetic and pharmacodynamic changes in 
paediatric patients introduce unique sources of error in the 
paediatric setting.  For example, paediatric dosing 
strategies are often age-specific and require individual dose 
calculations according to weight or body surface area.4 In 
addition, paediatric prescribing is frequently off-label5, and 
practice may vary between hospitals6 and prescribers.7  
Strategies that aim to minimise erroneous and suboptimal 
prescribing include the use of standardised guidelines and 
terminology, as well as quality and safety initiatives that 
target medications associated with high risk of error or 
complication, such as antimicrobials.8 Antimicrobial 
stewardship (AMS) programs have demonstrated 
significant contributions to hospital patient safety by 
detecting errors and educating staff on practices that 
optimise antimicrobial selection, dosage, route and 
duration.9   
With a broad range of strategies and individualised hospital 
practices, there is a recognised need for practical 
orientation for medical officers.8 In this study, we assessed 
baseline AMS and paediatric safe prescribing knowledge 
among all non-consultant level medical staff (JMOs) as part 
of mandatory orientation at a tertiary paediatric hospital 
and evaluated subsequent prescribing behaviours by 
conducting routine prescribing audits.  The primary 
objective of the study was to determine the educational 
requirements for JMOs who were newly employed by the 
hospital and those with prior local experience. A secondary 
objective was to assess the quality of prescribing in the 
three months after completing baseline assessment and 
orientation. 
 
METHODS 
On 2 February and 6 February 2017 all JMOs who attended 
one of three mandatory education sessions on AMS and 
safe prescribing were offered wireless keypad devices and 
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invited to participate in an anonymous and voluntary 
survey. The survey questions were presented to JMOs 
throughout the AMS and safe prescribing session on 
presentation slides created in Microsoft PowerPoint 
(Microsoft Corporation, Redmond, Washington). JMO 
responses entered using the keypad devices were captured 
in real-time using an audience response system (KP1, 
Sydney, NSW) and presented as part of the session.  From 8 
February to 7 May 2017 weekly prescribing audits were 
conducted across the hospital using a convenience 
sampling technique whereby the sample was easily 
accessible to the auditor.10 Inpatient wards were scanned 
for patients with current and available medication charts 
with a target of 60 patients each month to ensure 
sustainability. Audit results were reported to JMOs by the 
JMO unit as part of the JMO newsletter. Approval to 
conduct the survey and prescribing audit was granted by 
the local hospital research ethics committee as a quality 
improvement project (QIE-2017-02-04), and ratified by the 
University of Technology Research Ethics Committee.   
Setting 
This study was conducted at a 170-bed university-affiliated 
tertiary paediatric hospital in Sydney, New South Wales. 
The hospital employs JMOs with two or more years of post-
registration experience that may or may not include prior 
paediatric experience. During their employment, JMOs may 
be based onsite at the tertiary hospital or seconded to one 
of 23 different paediatric sites across New South Wales, 
Australian Capital Territory and the Northern Territory.  
Orientation is mandatory for JMOs and includes attendance 
at a face-to-face AMS and safe prescribing session designed 
by medical and pharmacy staff. The session reinforces 
aspects of safe prescribing in children, introduces local 
practice expectations and includes demonstrations of how 
to access local medication-related resources. The 
information is also summarised in the hospital’s Junior 
Medical Staff Handbook. The Handbook is updated annually 
and lists frequently used guidelines, prescribing “tips” and 
prescriber responsibilities. The responsibilities include 
obtaining approval for the use of restricted antimicrobials 
according to the hospital’s computerised clinical decision 
support and approval system (CDSS, Guidance MS, 
Melbourne, Australia) as part of the local AMS policy. 
Technical training on the use of the CDSS has been in place 
since its implementation in 2012 and is addressed during a 
separate face-to-face session. 
Since 2015, the time allocated for the safe prescribing 
session has been extended annually in order to cover 
broader aspects of paediatric medication use from the 
point of admission to discharge with a focus on 
antimicrobial use. However, JMO’s baseline knowledge and 
participation had never been formally assessed.  
AMS and safe prescribing session and survey 
JMOs who were employed by the hospital and working on 
site in the week before the start of term 1, 2017 (6 
February 2017) attended one of two abridged face-to-face 
orientation programs that each included a 40 minute AMS 
and safe prescribing session. JMOs who had spent the 
previous 3-month term in another facility attended a longer 
face-to-face orientation program with a 60 minute AMS 
and safe prescribing session. 
Presentation content and survey questions were designed 
by paediatric pharmacists with experience in quality use of 
medicines, medication safety and AMS. Content was 
finalised after feedback was received from: a consultant 
paediatrician responsible for general paediatric training, 
the hospital’s chief resident medical officer, an advanced 
trainee in paediatrics, and the lead infectious diseases 
consultant for AMS. Survey questions were not piloted 
among JMOs in order to limit pre-exposure to the 
assessment questions and maximise the number of 
responses.11 The content included case studies, 
unidentified errors, and examples of best practice in vital 
aspects of safe and appropriate medication use in children 
from admission to discharge. The examples included: 
• Medication history taking12 and documentation of 
adverse drug reactions (ADRs).13 
• Medication information resources. 
• AMS principles, clinical standards and indicators for 
AMS14, local policies, and JMO roles.  
• National standard terminology and error-prone 
abbreviations.15  
• Safe prescribing in accordance with national quality use 
of medicines indicators16 and the paediatric National In-
patient Medication Chart (NIMC).13  
• Local, legislative and Commonwealth funding prescription 
requirements.  
• Medication documentation requirements for hospital 
discharge summaries. 
Priority areas were determined after consideration of 
current practice observed in local audits and the potential 
risk of harm. Survey questions presented throughout the 
session were designed to enhance participation, engage 
JMOs and assess basic concepts before each topic was 
introduced in the presentation slides.  
Informed consent was obtained from JMOs at the 
beginning of each session. JMOs in attendance were 
informed that their participation in the survey was 
voluntary, anonymous and there were no incentives 
encouraging involvement. Participating JMOs could elect 
not to respond to individual questions and withdraw at any 
time. Any data collected through the audience response 
system prior to their withdrawal could not, however, be 
excluded due to the anonymous nature of the assessment.  
During the session, a presenter read aloud each assessment 
question and all answer options. The audience response 
system remained open to receive keypad responses until 
there was a consensus among the attending JMOs that 
responses had been submitted. Results were presented in 
the form of a graphical chart after the close of each survey 
question. The correct response was confirmed by the 
presenter; incorrect responses prompted further 
exploration of the topic and clarification as part of the 
session. All response options were multiple-choice, ranging 
from binary responses (yes or no, true or false) to a 
maximum of 5 response options.  
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Data collection and extraction 
Responses captured during each session were extracted 
from each of the session presentations with the use of the 
audience response system software and combined into a 
single database. Codes were assigned to each session and 
keypad combination. Attendance records obtained from 
the Junior Medical Unit determined the sample frame. 
Prescribing audits assessed all current medication orders 
for each patient.  ADR documentation, error-prone 
abbreviations, paediatric prescribing, and orders for 
intermittent therapy (non-daily administration) were 
collected in accordance with national quality use of 
medicines indicator definitions.16 Two additional NIMC 
criteria were also collected, the percentage of medication 
orders with a documented indication, and the percentage 
of “pro re nata” (PRN or “when necessary”) orders with the 
maximum number of doses in 24 hours specified. 
Statistical Analysis 
Descriptive statistics were performed in SPSS 24 (IBM, 
Armonk, NY). All survey responses and prescription audit 
criteria were analysed as categorical data and reported as 
percentages rounded to the closest whole number. Chi-
Square tests were used to explore differences in proportion 
of correct survey responses between JMOs who identified 
themselves as new employees and those who had 
previously worked in the institution. Participation was 
reported for each survey question separately as the 
proportion of the sample frame with a captured keypad 
response (i.e. number of responses/number of JMOs in 
attendance). The extent of participation by individual JMOs 
throughout each session was reported as the percentage of 
questions with a response from a single keypad. Kruskal-
Wallis tests assessed differences in prescribing each month 
after the AMS and safe prescribing session. All statistical 
tests were two-tailed with P values <0.05 considered 
statistically significant. 
 
RESULTS  
Survey 
Two hundred JMOs attended orientation, 89 were assigned 
to an abridged program. Most JMOs had experience in 
paediatrics; more than half were in the process of 
completing either Basic or Advanced Paediatric Training. A 
small proportion of JMOs were Training in other specialties 
such as general practice, surgical subspecialties, intensive 
care and emergency medicine (Figure 1).  More than half of 
all JMOs present responded to at least 80% of the survey 
questions in their session (Figure 2). The response rate for 
individual questions ranged between 31% and 78%. Thirty-
nine percent of JMOs (77/200) reported working at the 
hospital in the previous 12 months and 33% (65/200) 
indicated they had not. 
Information Gathering and clinical decision-making  
Almost all JMOs (98%) were aware of NIMC requirement to 
record the specific reaction, reaction type and the date of 
occurrence as part of complete documentation. Overall, 
85% (132/155) of participating JMOs correctly identified 
the national paediatric medication reference as the 
preferred guide for medicines information and dosing at 
the institution.  Among those who reported their prior local 
experience, the correct option was selected by 96% of 
JMOs who had worked at the hospital in the previous 12 
months and 71% of those who had not (p=0.001) (Table 1).  
Figure 1. Medical staff in attendance during safe prescribing and 
antimicrobial stewardship orientation. 
§Basic Physician or Paediatric Trainees have committed to, or are in 
the process of completing Paediatric Training, with 2 or more years 
of experience; ^Unaccredited Trainees hold registrar positions but 
may not have participated in the full College training program; 
#Advanced Trainees have completed Basic Training; ^^Fellows have 
completed training; *Training in Other Specialty includes: Intensive 
Care, Emergency Medicine, Surgical Subspecialties, General Practice 
and Dermatology 
Figure 2. Medical staff participation throughout orientation.   
Proportion of questions with responses from JMOs in 40 minute 
session (14 questions) and 1 hour session (17 questions)  
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Communicating and reviewing decisions   
Between 70% and 74% of JMOs responded to questions 
about antimicrobial prescribing. Among those who 
participated, 95% had heard the term antimicrobial 
stewardship, and knew that prescriptions for empiric 
antibiotics should document both the indication and a 
planned review date in the medical record. Very few 
respondents considered it appropriate to wait until 72 
hours of antibiotic therapy or the next consultant ward 
round to review empiric antibiotic therapy. The majority 
indicated reviews should take place at least daily (78%) or 
every 48 hours (20%). Almost all JMOs recognised that 
fever alone was not an exclusion for intravenous to oral 
antimicrobial switch (94%). 
Ninety-two percent were aware of the correct method by 
which to cease an order on the NIMC, specifically, the need 
to document the date of cessation on the order (124/135). 
Non-standard terminology (i.e., “6/24” and “1/7) in the 
order “flucloxacillin PO 500mg 6/24 for 1/7” was identified 
by 85% of JMOs.  
Table 1. Assessment survey questions and JMO responses according to self-identified previous work experience at the study hospital# 
Assessment questions and responses 
(Responses rate, all responses/all JMOs, %) 
Overall 
JMO 
responses,  
n (%) 
Previous 
work 
experience 
unknown
^
, 
n (%) 
JMOs 
worked at 
the 
hospital in 
the 
previous 
year, 
n (%) 
JMOs who 
did not 
work at 
the 
hospital in 
the 
previous 
year, 
n (%) 
Have you heard of the term “Antimicrobial Stewardship” or AMS?  
Responses (RR 140/200, 70%) 140 20 63 57 
Heard of AMS 133 (95) 20 (100) 61 (97) 52 (91) 
Have not heard of AMS 7 (5) 0 2 (3) 5 (9) 
In addition to name, signature and date, which of the following indicates a correct example of adverse drug reaction documentation?   
Responses (RR 148/200, 74%) 148 19 69 60 
Rash, 20/11/2001 0(0) 0(0) 0 (0) 0 (0) 
Amoxycillin, 20/11/2001 0(0) 0(0) 0 (0) 0 (0) 
Amoxycillin, Rash, 20/11/2001 3(2) 1(5) 1(1) 1(2) 
Amoxycillin, Rash - urticaria, 20/11/2001 (correct) 145 (98*) 18 (95) 68 (99) 59 (98) 
For general prescribing the first reference should be: 
Responses (RR 155/200, 78%) 155 23 70 62 
Meds4Kids
§
 21 (14) 2 (9) 2 (3) 17 (27) 
UpToDate 0 0 0 0 
BNF for Children 2 (1) 0 1 (1) 1 (2) 
AMH-CDC (correct)** 132 (85*) 21 (91) 67 (96) 44 (71) 
3-Prescriptions for empiric antimicrobial use should document both the indication and planned review date  
Responses (RR 141, 71%) 141 23 65 53 
True (correct) 136 (96*) 22 (96) 63 (97) 51 (96) 
False 5 (4) 1 (4) 2 (3) 2 (4) 
It is unnecessary to document the date on a ceased medication order as long as both the prescription and administration sections of a medication 
chart are crossed out.  
Responses (RR 135/200, 68%) 135 18 63 54 
True 11 (8) 1 (6) 7 (11) 3 (6) 
False (correct) 124 (92*) 17 (94) 56 (89) 51 (94) 
“Flucloxacillin PO 500mg 6/24 for 1/7” is a safe prescription if one day of antibiotic therapy is required before discharge  
Responses (RR 141/200, 71%) 141 18 69 54 
True 27 (19) 5 (28) 13 (19) 9 (17) 
False (correct) 114 (81*) 13 (72) 56 (81) 45 (83) 
How many of the following are acceptable when prescribing once DAILY prescriptions: OD, d, o.d., qd, QD, mane, M, N nocte?  
Responses (153/200, 77%) 153 20 71 62 
One  16(10) 3(15) 6(8) 7(11) 
Three  24(16) 4(20) 8(11) 12(19) 
Two (correct) 112 (73*) 13 (65) 56 (79) 43 (69) 
Five  1 (<1) 0 1 (1) 0 (0) 
How many of the following abbreviations are appropriate: subcut, sc, S/C, SC, S/L, SL, IO, D/C?  
Total number of responses (RR 148/200, 74%) 148 23 67 58 
Three  30 (20) 4 (17) 12 (18) 14 (24) 
One (correct) 79 (53*) 13(57) 39 (58) 27 (47) 
Two  32 (22) 4 (17) 14 (21) 14 (24) 
Five  4 (3) 2 (9) 1 (1) 1 (2) 
Eight  3 (2) 0 1 (1) 2 (3) 
U and IU are acceptable abbreviations for units 
Responses (RR 149/200, 75%) 149 21 69 59 
True 8 (5) 2 (10) 4 (6) 2 (3) 
False (correct) 141 (95*) 19 (90) 65 (94) 57 (97) 
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Almost all JMOs recognised that the error-prone 
abbreviations “IU” and “U” were unacceptable when 
prescribing medications measured in “international units” 
and “units” (95%, 141/149). Almost 30% of JMOs were 
unable to identify the standard terms “mane” and “nocte” 
from terms that should not be used (OD, D, o.d, M, N, QD, 
qd). Only 53% could differentiate the standard term 
“subcut” from the error-prone abbreviations. When asked 
to count the erroneous and non-standard terms present in 
the order “clonidine PO .030 mcg 8° x3d then review”, only 
60% correctly identified all five (Table 1). Although the 
response rate was considerably lower than any other 
question (31%, 62/200), 87% of participants were aware 
that chemical symbols should not be used when prescribing 
electrolytes.  
Discharge prescriptions  
The 60-minute AMS and safe prescribing session included 
three additional assessment questions to gauge awareness 
of prescribing requirements for special authority and 
Schedule 8 medicine (drugs of addiction, e.g. oxycodone, 
fentanyl, etc.). Approximately 90% of JMOs were 
reportedly aware that standard hospital prescription forms 
were unsuitable for supply from a retail pharmacy. Over 
90% were aware that multiple Schedule 8 medicines could 
not be prescribed on a single discharge prescription, and 
that pre-printed patient identification should not be used 
for Schedule 8 discharge prescriptions (Table 2).  
Prescribing Audit 
Nine hundred and seventy-six medication orders were 
reviewed for 166 patients between 7 February and 6 May 
2017. No statistically significant changes in prescribing 
were observed during the auditing period. Over the three 
months of auditing, between 63 to 75% of audited patients 
had an appropriately documented ADR (Table 3). The 
maximum number of PRN doses was included on 77% of 
PRN orders, ranging from 84% of orders in period 1 and 
70% in period 3 (p=0.08); on average 46% of orders 
included a documented indication. 
Error-prone abbreviations were observed in 5 to 8% of 
medication orders in the first two months and 2% in period 
3 (p=0.09). Almost all intermittent medications were 
documented according to the national QUM indicator with 
the non-administration days crossed out (27/28). Dose 
calculations were consistently documented in 
approximately half of all orders.  
 
DISCUSSION 
JMOs who participated in this baseline assessment survey 
demonstrated an excellent understanding of best practice 
for safe and appropriate prescribing. Almost all JMOs were 
familiar with AMS and were aware of the national AMS 
clinical indicators for empiric antimicrobial therapy that 
require prescribers to document the indication and date of 
clinical review in the medical record.14 JMOs also 
recognised that fever alone was not an indication for 
intravenous antibiotic therapy, and that empiric antibiotic 
Table 1 (Cont.). Assessment survey questions and JMO responses according to self-identified previous work experience at the study hospital# 
Assessment questions and responses 
(Responses rate, all responses/all JMOs, %) 
Overall 
JMO 
responses, n 
(%) 
Previous 
work 
experience 
unknown
^
, 
n (%) 
JMOs 
worked at 
the 
hospital in 
the 
previous 
year, 
n (%) 
JMOs who 
did not 
work at the 
hospital in 
the 
previous 
year, 
n (%) 
How many errors (abbreviations symbols etc.) are there in the prescription “clonidine PO .030 mcg 8° x3d then review”  
Responses (RR 144/200, 72%) 144 22 66 56 
Five (correct) 86 (60*) 14 (64) 41 (62) 31 (55) 
Two  1 (<1) 0 (0) 1 (2) 0 (0) 
Three  37 (26) 7 (32) 14 (21) 16 (29) 
Six  20 (14) 1 (4) 10 (15) 9 (16) 
Chemical symbols (MgSo4, KCl etc.) should be used when ordering electrolytes  
Responses (62/200, 31%) 62 7 47 8 
True 8(12.9) 1(14.3) 7(14.9) 0 
False (correct) 54 (87.1*) 6 (85.7) 40 (85.1) 8 (100) 
Empiric antibiotic therapy should be reviewed:  
Responses (RR 147/200, 74%) 147 23 67 57 
48 hours after initiation 29 (20) 4 (17) 13 (19) 12 (21) 
At least daily (correct) 114 (78*) 19 (83) 50 (75) 45 (79) 
72 hours after initiation 1 (<1) 0 1 (1) 0 
On consultant ward round 3 (2) 0 3 (5) 0 
Paediatric patients should remain on IV antimicrobials as long as they are febrile  
Responses (RR 145/200, 73%) 145 22 63 60 
True 8 (6) 3 (14) 1 (2) 4 (7) 
False (correct) 137 (94*) 19 (86) 62 (98) 56 (93) 
#Unless otherwise stated there were no statistically significant differences in the proportion of correct responses between groups; ^JMOs who 
did not respond when asked if they had worked in the study hospital in the previous year; §Intranet resource belonging to another tertiary 
paediatric hospital with links to their own hospital specific guidelines;** p=0.001; BNF for Children=British National Formulary for Children; 
AMH CDC= Australian Medicines Handbook-Children’s Dosing Companion; Uptodate®; IV=Intravenous; RR: Response rate; *Overall percentage 
correct 
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therapy should be reassessed at regular intervals.  Standard 
and error-prone terminology was generally differentiated 
by JMOs. However, the very low response rate to our 
question about the use of chemical symbols suggests that 
some JMOs might have chosen not to participate due to 
uncertainty. If true, this could have implications elsewhere 
in our survey.    
By conducting our survey during face-to-face orientation, 
we had direct contact with all JMOs. In addition to 
assessing knowledge amongst respondents, we were able 
to report participation at each assessment question during 
the AMS and safe prescribing session. Response rate in this 
survey is of particular importance due to the conditions in 
which it was conducted; attendance was mandatory and 
the sessions were held during protected teaching time so 
that JMOs were not distracted by their day-to-day tasks. 
The 1-hour orientation was held at the beginning of the 
new term, before JMOs were assigned any designated 
responsibilities to a medical unit or cohort of patients that 
might prevent them from attending or concentrating on 
formal teaching.8 Despite the ideal conditions, 15% of JMOs 
overall did not respond to a single question during the AMS 
and safe prescribing session, and only 13% responded to all 
the survey questions in their session.  
JMOs in our study most readily participated when asked to 
identify preferred medication information resources, in 
keeping with other research that suggests JMOs view 
information on guidelines and protocols favourably8, and 
rely heavily on online sources of information.17  
It is widely recognised that prescribing is complex, and 
influenced by a range of personal factors such as baseline 
knowledge, awareness and attitudes, as well as 
environmental interruptions and social dynamics.1,18 The 
results of our prescribing audits reinforce these conclusions 
and are consistent with other evaluations that target 
prescribing behaviour. Documentation was not ideal at any 
point in the months following the session despite the 
results of our baseline survey and the prompts 
incorporated into the paediatric NIMC that outline where 
to record the maximum PRN dose in 24 hours, indication 
for use, the prescriber’s dose calculations and how to 
document an ADR. Incomplete ADR documentation is of 
particular interest for AMS programs, as patients labelled 
with allergies to commonly used first line antimicrobials 
Table 2. Discharge Prescription Assessment Questions
#
 
Assessment Question and response options (n=111) Overall (%) 
Previous work 
experience 
unknown
^
, 
n (%) 
JMOs worked 
at the hospital 
in the previous 
year, 
n (%) 
JMOs who did 
not work at the 
hospital in the 
previous year, 
n (%) 
A PBS Authority may be obtained from an outside (community) pharmacy with a hospital discharge prescription? 
Responses (RR 77/111) 77 11 19 47 
True 8 (10) 2 (18) 2 (11) 4 (9) 
False (correct) 69 (90*) 9 (82) 17 (89) 43 (91) 
When prescribing Schedule 8 medications a separate discharge prescription is required for each form of the medication? 
Responses (RR 83/111) 83 13 20 50 
True (correct) 78 (94*) 11 (85) 20 (100) 47 (94) 
False 5 (6) 2 (15) 0 (0) 3 (6) 
Addressograph (Patient ID stickers) may be used on discharge prescriptions for Schedule 8 medications 
Responses (RR 84/111) 84 12 20 52 
True 7 (8) 0 (0) 2 (10) 5 (10) 
False (correct) 77 (92*) 12 (100) 18 (90) 47 (90) 
#No statistically significant differences between groups; ^ Unknown=No response provided when asked if they had worked in the study 
hospital in the previous year; *Overall percentage correct  
Schedule 8=Drugs of Dependence (oxycodone, morphine, fentanyl etc); PBS=Pharmaceutical Benefits Scheme; Patient ID=Patient 
identification 
Table 3. Prescribing behaviour observed after AMS and Safe Prescribing session* 
Prescription characteristics 
Period 1 
n (%) 
Period 2 
n (%) 
Period 3 
n (%) 
p-value 
Patients reviewed 40 65 61 
 
Prescriptions per patient,  median (IQR) 6.5 (4 - 10) 4 (3 - 8) 5 (4 - 7) 0.03 
National quality use of medicines Indicators
+
 
Patients with ADR documented on current medication chart  26/40 (65) 41/65 (63) 46/61(75) 0.30 
Prescriptions with error prone abbreviations 13/284 (5) 27/345 (8) 7/347 (2) 0.09 
Paediatric medication orders that include the correct dose per kilogram or BSA  91/183 (50) 107/221 (48) 135/262 (52) 0.88 
Medication orders for intermittent therapy prescribed safely 14/14 (100) 5/6 (83) 8/8 (100) 0.22 
Local Indicators  
Order with indication documented   147/284 (52) 157/345 (46) 145/347 (42) 0.37 
PRN orders that specified the maximum number of doses every 24 hours  61/73 (84) 83/103 (81) 80/115 (70) 0.08 
ADR: Adverse drug reaction; BSA: Body surface area; IQR: Interquartile range; PRN: When required 
*Period 1: 7 February-6 March 2017, Period 2: 7 March to 6 April, Period 3: 7 April to 6 May 2017 
+ National quality use of medicines indicators specified as:  
Indicator 3.2 ADR status must be documented as nil known, unknown or include the drug, reaction, type and date.   
Indicator 3.3 Error prone abbreviations: Qd, OD, U, mcg, trailing zeros or failure to include a leading zero when the dose is less than a one. 
Adapted to include abbreviations IT, SC and µ  
Indicator 3.4 Paediatric dose must be documented, safe and effective,  
Indicator 3.5 Intermittent therapy non-administration days must be crossed out, days of therapy specified 
Mostaghim M, Snelling T, Katf H, Bajorek B. Paediatric antimicrobial stewardship and safe prescribing-an assessment of medical 
staff knowledge and behaviour. Pharmacy Practice 2018 Apr-Jun;16(2):1198.  
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(e.g., penicillins) may be treated with alternate broad-
spectrum agents that are associated with greater risk of 
adverse effects.19  
This study has several limitations. We were unable to 
determine whether the decision to participate during the 
session reflected individual JMOs confidence or their 
interest in the content. We also cannot exclude alternate 
scenarios such as temporary audience response system 
malfunctions or JMOs using the keypad incorrectly by 
accidentally or intentionally selecting incorrect answers. In 
all these scenarios, our results could underreport JMO 
knowledge and participation. Our survey questions were 
relatively basic for our cohort of JMOs who had prior 
hospital experience, and in some cases, were close to 
completing their paediatric training. Nevertheless, even 
without JMO’s usual workplace distractions we identified 
gaps in knowledge and observed examples of error-prone 
prescribing and incomplete documentation. Finally, our 
study design was not ideal. A sufficiently powered 
randomised control trial was not feasible in our setting and 
may have been inappropriate. We did not limit our 
prescribing audit to JMOs and may have included 
prescriptions written by Consultant Paediatricians. 
However, this would be rare as JMOs are most frequently 
tasked with prescription writing responsibilities, even if 
they are not responsible for prescribing decisions.8  
Further studies are needed to determine whether face-to-
face education adopted here improves prescribing 
behaviours, and how suboptimal prescribing can be 
addressed despite excellent or adequate knowledge of the 
expected prescribing practice. Targeted behaviour change 
strategies underpinned by a deeper understanding of 
prescriber’s perceptions and motivations are warranted 
and should be further explored. 
 
CONCLUSIONS 
JMO respondents demonstrated sound baseline knowledge 
of safe prescribing and good antibiotic prescribing 
practices. Potential gaps in knowledge included the use of 
chemical symbols and error-prone abbreviations. 
Participation in a baseline assessment survey facilitated by 
an audience response system was adequate but not ideal 
despite eradicating distractions such as clinical or 
administrative responsibilities. Suboptimal documentation 
in the months following the knowledge assessment 
suggests prescribing is influenced by factors beyond 
knowledge and awareness. 
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